MedTrace Logo

Fluoxetine vs. Brief Psychotherapy for Major Depression

NCT00714779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2008-07-14

No results posted yet for this study

Summary

In this study we compare two treatments for major depression - fluoxetine and brief psychodynamic psychotherapy. In addition to more traditional outcome measures, we also measure the densities of 5HT-1A and D-2 receptors before and after the treatment. The main hypothesis is that brief psychotherapy is as effective as fluoxetine.

Conditions

Interventions

DRUG

Fluoxetine

20-40 mg / day orally

BEHAVIORAL

Short-term psychodynamic psychotherapy

1 session / week for 16 weeks

Sponsors & Collaborators

  • KELA

    collaborator UNKNOWN

  • Finnish State Grant

    collaborator UNKNOWN

  • University of Turku

    lead OTHER

Principal Investigators

  • Hasse Karlsson, MA, MD, PhD · University of Helsinki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2004-12-31
Completion
2004-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714779 on ClinicalTrials.gov